Mustang Bio, Inc.

NASDAQ:MBIO

0.25 (USD) • At close November 7, 2024
Bedrijfsnaam Mustang Bio, Inc.
Symbool MBIO
Munteenheid USD
Prijs 0.248
Beurswaarde 9,024,026
Dividendpercentage 0%
52-weken bereik 0.128 - 1.73
Industrie Biotechnology
Sector Healthcare
CEO Dr. Manuel Litchman M.D.
Website https://www.mustangbio.com

An error occurred while fetching data.

Over Mustang Bio, Inc.

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies

Vergelijkbare Aandelen

ImmuCell Corporation logo

ImmuCell Corporation

ICCC

3.53 USD

Neuronetics, Inc. logo

Neuronetics, Inc.

STIM

1.08 USD

Silver Spike Investment Corp. logo

Silver Spike Investment Corp.

SSIC

10.735 USD

Great Elm Group, Inc. logo

Great Elm Group, Inc.

GEG

1.79 USD

LifeMD, Inc. logo

LifeMD, Inc.

LFMD

5.13 USD

Curis, Inc. logo

Curis, Inc.

CRIS

4.35 USD

Cyteir Therapeutics, Inc. logo

Cyteir Therapeutics, Inc.

CYT

3.02 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)